nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Additional Cytogenetic Abnormalities with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era
|
Akahoshi, Yu |
|
|
24 |
10 |
p. 2009-2016 |
artikel |
2 |
A Modified Intensive Strategy to Prevent Cytomegalovirus Disease in Seropositive Umbilical Cord Blood Transplantation Recipients
|
Hill, Joshua Aiden |
|
|
24 |
10 |
p. 2094-2100 |
artikel |
3 |
Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma
|
Kansagra, Ankit |
|
|
24 |
10 |
p. 2127-2132 |
artikel |
4 |
ASBMT News
|
|
|
|
24 |
10 |
p. 2169-2170 |
artikel |
5 |
Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75
|
Sidiqi, M. Hasib |
|
|
24 |
10 |
p. 2157-2159 |
artikel |
6 |
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
|
de Lima, Marcos |
|
|
24 |
10 |
p. 2017-2024 |
artikel |
7 |
Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia
|
Wang, Youjin |
|
|
24 |
10 |
p. 2003-2008 |
artikel |
8 |
Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
|
Gagelmann, Nico |
|
|
24 |
10 |
p. 2101-2109 |
artikel |
9 |
Cost Effectiveness of Hematopoietic Stem Cell Transplantation Compared with Transfusion Chelation for Treatment of Thalassemia Major
|
John, M. Joseph |
|
|
24 |
10 |
p. 2119-2126 |
artikel |
10 |
Cytomegalovirus Infection Among Cord Blood Allogeneic Transplantation Recipients: Low Incidence of Cytomegalovirus Events without High-Dose Valacyclovir Prophylaxis
|
Knoll, Bettina M. |
|
|
24 |
10 |
p. 2164-2165 |
artikel |
11 |
Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program
|
McDonald, Marissa K. |
|
|
24 |
10 |
p. 2081-2087 |
artikel |
12 |
Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients
|
Suárez-Lledó, María |
|
|
24 |
10 |
p. 2088-2093 |
artikel |
13 |
Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
|
Song, Yang |
|
|
24 |
10 |
p. 1981-1989 |
artikel |
14 |
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes
|
McCurdy, Shannon R. |
|
|
24 |
10 |
p. 2056-2064 |
artikel |
15 |
Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study
|
Spellecy, Ryan |
|
|
24 |
10 |
p. 2145-2151 |
artikel |
16 |
Editorial Board
|
|
|
|
24 |
10 |
p. A6 |
artikel |
17 |
Expression of Intracellular Reactive Oxygen Species in Hematopoietic Stem Cells Correlates with Time to Neutrophil and Platelet Engraftment in Patients Undergoing Autologous Bone Marrow Transplantation
|
Bai, Lijun |
|
|
24 |
10 |
p. 1997-2002 |
artikel |
18 |
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies
|
Katsanis, Emmanuel |
|
|
24 |
10 |
p. 2034-2039 |
artikel |
19 |
Haploidentical Transplants: An Answer to Ethical Challenges on the Use of Preimplantation Donor Selection
|
Rondelli, Damiano |
|
|
24 |
10 |
p. 2167-2168 |
artikel |
20 |
Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources
|
Ishio, Takashi |
|
|
24 |
10 |
p. 1990-1996 |
artikel |
21 |
Higher CD45RA+ Regulatory T Cells in the Graft Improves Outcome in Younger Patients Undergoing T Cell–Replete Haploidentical Transplantation: Where Donor Age Matters
|
Jaiswal, Sarita Rani |
|
|
24 |
10 |
p. 2025-2033 |
artikel |
22 |
Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients
|
Ogimi, Chikara |
|
|
24 |
10 |
p. 2160-2163 |
artikel |
23 |
It's Not All in the Conditioning or the Perils of Early Trial Cessation
|
Scott, Bart L. |
|
|
24 |
10 |
p. 1957-1958 |
artikel |
24 |
Masthead (Purpose and Scope)
|
|
|
|
24 |
10 |
p. A4 |
artikel |
25 |
Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease
|
Fan, Xiubo |
|
|
24 |
10 |
p. 1971-1980 |
artikel |
26 |
Officers and Directors of ASBMT
|
|
|
|
24 |
10 |
p. A8 |
artikel |
27 |
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
|
Jacobsohn, David A. |
|
|
24 |
10 |
p. 2040-2046 |
artikel |
28 |
Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant
|
Vardhana, Santosha |
|
|
24 |
10 |
p. 2133-2138 |
artikel |
29 |
Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation
|
Kröger, Nicolaus |
|
|
24 |
10 |
p. 2152-2156 |
artikel |
30 |
Propensity Score Analysis of Conditioning Intensity in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation
|
Huselton, Eric |
|
|
24 |
10 |
p. 2047-2055 |
artikel |
31 |
Providing Level-of-Match Information to Perfectly Matched Unrelated Stem Cell Donors: Evaluating Acceptability and Potential Changes in Donor Availability
|
Switzer, Galen E. |
|
|
24 |
10 |
p. 2110-2118 |
artikel |
32 |
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial
|
Clemmons, Amber B. |
|
|
24 |
10 |
p. 2065-2071 |
artikel |
33 |
Relationship between Aging and Hematopoietic Cell Transplantation
|
Cupit-Link, Margaret C. |
|
|
24 |
10 |
p. 1965-1970 |
artikel |
34 |
Reply to Author
|
Hill, Joshua A. |
|
|
24 |
10 |
p. 2166 |
artikel |
35 |
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant
|
Strouse, Christopher |
|
|
24 |
10 |
p. 2072-2080 |
artikel |
36 |
Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis
|
Kako, Shinichi |
|
|
24 |
10 |
p. 2139-2144 |
artikel |
37 |
Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation
|
Sullivan, Keith M. |
|
|
24 |
10 |
p. 1961-1964 |
artikel |
38 |
Table of Contents
|
|
|
|
24 |
10 |
p. A9-A14 |
artikel |
39 |
Ten Things to Know About Primary Mediastinal B Cell Lymphoma
|
Avivi, Irit |
|
|
24 |
10 |
p. 1959-1960 |
artikel |